1,547
Views
16
CrossRef citations to date
0
Altmetric
Articles

Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system

, , , , , , , & show all
Pages 552-564 | Received 06 Feb 2018, Accepted 06 Apr 2018, Published online: 24 Apr 2018

References

  • Ahmadi Nasab N, Hassani Kumleh H, Beygzadeh M, et al. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 2018;46:75–81.
  • Wang F, Wang Y, Ma Q, et al. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Artif Cells Nanomed Biotechnol. 2017;45:1530–1538.
  • Yamamoto H, Kuno Y, Sugimoto S, et al. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release. 2005;102:373–381.
  • Yang X, Zhang C, Qiao C, et al. A simple and convenient method to synthesize N-[(2-hydroxyl)-propyl-3-trimethylammonium chitosan chloride in an ionic liquid. Carbohydr Polym. 2015;130:325–332.
  • Li SD, Li PW, Yang ZM, et al. Synthesis and characterization of chitosan quaternary ammonium salt and its application as drug carrier for ribavirin. Drug Deliv. 2014;21:548–552.
  • Soares PI, Sousa AI, Ferreira IM, et al. Towards the development of multifunctional chitosan-based iron oxide nanoparticles: optimization and modelling of doxorubicin release. Carbohydr Polym. 2016;153:212–221.
  • Kaur R, Garg T, Das Gupta U, et al. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 2016;44:182–187.
  • Zhang Y, Zhang J. Preparation of budesonide nanosuspensions for pulmonary delivery: characterization, in vitro release and in vivo lung distribution studies. Artif Cells Nanomed Biotechnol. 2016;44:285–289.
  • Bhardwaj A, Mehta S, Yadav S, et al. Pulmonary delivery of antitubercular drugs using spray-dried lipid-polymer hybrid nanoparticles. Artif Cells Nanomed Biotechnol. 2016;44:1544–1555.
  • Liang Z, Ni R, Zhou J, et al. Recent advances in controlled pulmonary drug delivery. Drug Discov Today. 2015;20:380–389.
  • Feng R, Zhang Z, Li Z, et al. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Drug Deliv. 2014;23:1962–1971.
  • Wang Y, Zhu LH, Chen AZ, et al. One-step method to prepare PLLA porous microspheres in a high-voltage electrostatic anti-solvent process. Materials. 2016;9:368.
  • Chen AZ, Zhao C, Wang SB, et al. Generation of porous poly-L-lactide microspheres by emulsion-combined precipitation with a compressed CO2 antisolvent process. J Mater Chem B. 2013;1:2967–2975.
  • Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6:67–74.
  • Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science. 1997;276:1868–1871.
  • Hirst PH, Pitcairn GR, Weers JG, et al. In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler. Pharm Res. 2002;19:258–264.
  • Kim TK, Yoon JJ, Lee DS, et al. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials. 2006;27:152–159.
  • Vitali L, Della Betta F, Cost AC, et al. New multilayer coating using quaternary ammonium chitosan and κ-carrageenan in capillary electrophoresis: application in fast analysis. Talanta. 2014;123:45–53.
  • Wu Y, Wu S, Hou L, et al. Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery. Eur J Pharm Biopharm. 2012;81:486–497.
  • Wei W, Lv PP, Chen XM, et al. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression. Biomaterials. 2013;34:3912–3923.
  • Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59:645–666.
  • Kanokpanont S, Yamdech R, Aramwit P. Stability enhancement of mulberry-extracted anthocyanin using alginate/chitosan microencapsulation for food supplement application. Artif Cells Nanomed Biotechnol. 2018;46:773–782.
  • Balmayor ER, Tuzlakoglu K, Azevedo HS, et al. Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications. Acta Biomater. 2009;5:1035–1045.
  • Kankala RK, Zhang YS, Wang SB, et al. Supercritical fluid technology: an emphasis on drug delivery and related biomedical applications. Adv Healthcare Mater. 2017;6:1–31.
  • Wu X, Zhang WF, Hayes D Jr, et al. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery. Int J Nanomedicine. 2013;8:1269–1283.
  • Holt J. The MMAD Calculator. 2009. Available from http://www.mmadcalculator.com/
  • Chamieh J, Zimmermann Y, Boos A, et al. Preparation and characterisation of silica monoliths using a triblock copolymer (F68) as porogen. J Colloid Interface Sci. 2009;340:225–229.
  • Ma B, Li X, Qin A, et al. A comparative study on the chitosan membranes prepared from glycine hydrochloride and acetic acid. Carbohydr Polym. 2013;91:477–482.
  • Zuo HG, Zhu JX, Zhan CR, et al. Preparation of malathion MIP-SPE and its application in environmental analysis. Environ Monit Assess. 2015;187:1144–1153.
  • Li J, Zhang Y. Porous polymer films with size-tunable surface pores. Chem Mater. 2007;19:2581–2584.
  • Meenach SA, Kim YJ, Kauffman KJ, et al. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery. Mol Pharmaceutics. 2012;9:290–298.
  • Jóhannsdóttir S, Jansook P, Stefánsson E, et al. Development of a cyclodextrin-based aqueous cyclosporin A eye drop Formulations. Int J Pharm. 2015;493:86–95.
  • Moffat JG, Qi S, Craig DQ. Spatial characterization of hot melt extruded dispersion systems using thermal atomic force microscopy methods: the effects of processing parameters on phase separation. Pharm Res. 2014;31:1744–1752.
  • Yamasaki K, Kwok PC, Fukushige K, et al. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former. Int J Pharm. 2011;420:34–42.
  • Tam JM, McConville JT, Williams RO, 3rd, et al. Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J Pharm Sci. 2008;97:4915–4933.
  • Chen X, Young TJ, Sarkari M, et al. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm. 2002;242:3–14.
  • Huang J, Cheng ZH, Xie HH, et al. Effect of quaternization degree on physiochemical and biological activities of chitosan from squid pens. Int J Biol Macromol. 2014;70:545–550.
  • Volodkin DV, Larionova NI, Sukhorukov GB. Protein encapsulation via porous CaCO3 microparticles templating. Biomacromolecules. 2004;5:1962–1972.
  • Sarisözen C, Arica B, Orman MN, et al. Optimization of prednisolone acetate-loaded chitosan microspheres using a 2(3) factorial design for preventing restenosis. Drug Deliv. 2010;17:178–186.
  • Gungor S, Okyar A, Erturk-Toker S, et al. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes. Drug Dev Ind Pharm. 2010;36:806–813.
  • Cai Y, Chen Y, Hong X, et al. Porous microsphere and its applications. Int J Nanomedicine. 2013;8:1111–1120.
  • Henderson RF. Use of bronchoalveolar lavage to detect lung damage. Environ Health Perspect. 1984;56:115–129.
  • Na L, Wang J, Wang L, et al. A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats. Eur J Pharm Sci. 2013;48:301–306.
  • Wong WS, Koh DS. Advances in immunopharmacology of asthma. Biochem Pharmacol. 2000;59:1323–1335.
  • Balsley MA, Malesevic M, Stemmy EJ, et al. A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation. J Immunol. 2010;185:7663–7670.
  • Aalbers R, Vogelmeier C, Kuna P. Achieving asthma control with ICS/LABA: a review of strategies for asthma management and prevention. Respir Med. 2015;111:1–7.
  • Ricciardolo FL, Petecchia L, Sorbello V, et al. Bradykinin B2 receptor expression in the bronchial mucosa of allergic asthmatics: the role of NF-kB. Clin Exp Allergy. 2016;46:428–438.
  • Pritchard KA Jr, Feroah TR, Nandedkar SD, et al. Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice. Am J Respir Cell Mol Biol. 2012;46:389–396.
  • Xie QM, Chen JQ, Shen WH, et al. Effects of cyclosporin A by aerosol on airway hyperresponsiveness and inflammation in guinea pigs. Acta Pharmacol Sin. 2002;23:243–247.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.